Author Archives: admin001

BriaCell Announces Private Placement of up to $600,000

BERKELEY, Calif., and VANCOUVER, British Columbia, September 20, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces Public Disclosure: Remarkable Responder in Combination Study of Lead Candidate with KEYTRUDA®

Material information is being presented concurrent with this press release at 9:35am Eastern Time at ...

BriaCell to Present September 19th at 2nd Annual Next Gen Immuno-Oncology Congress in Philadelphia

BERKELEY, Calif., and VANCOUVER, British Columbia, September 16, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces Closing of Upsized Non-Brokered Private Placement of $846,301.49

BERKELEY, Calif., and VANCOUVER, British Columbia, September 9, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces Participation at the 21st Annual Global Investment Conference in New York City September 8-10, 2019

BERKELEY, Calif., and VANCOUVER, British Columbia, August 27, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Appoints Richard J. Berman to Board of Directors

BERKELEY, Calif., and VANCOUVER, British Columbia, August 12, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces $350,000 Equity Investment by Board of Directors

BERKELEY, Calif., and VANCOUVER, British Columbia, July 23, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell’s Novel Technology and Clinical Data Published at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

BERKELEY, Calif., and VANCOUVER, British Columbia, May 28, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Approves New Board of Directors and Chairman at Annual and Special Meeting of Shareholders

BERKELEY, Calif., and VANCOUVER, British Columbia, May 13, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces Publication at American Society of Clinical Oncology (ASCO) Meeting and Presentation at Precision Breast Cancer Summit in Boston

BERKELEY, Calif., and VANCOUVER, British Columbia, April 23, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...